This inventor holds 1 USPTO granted patent. Top assignee: Alfa Wassermann, Inc.. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: Salvatore Mardente: Innovator in Pharmaceutical Compositions
Introduction
Salvatore Mardente is a notable inventor based in Turin, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. His work focuses on enhancing the efficacy and safety of pharmaceutical compositions.
Latest Patents
Mardente holds a patent for "Pharmaceutical compositions containing calcitonin in a spray dosing." This invention pertains to pharmaceutical compositions for intranasal administration, which utilize a spray dosing feeder. The calcitonin is dissolved in a physiological solution of sodium chloride, adjusted to a pH between 3.5 and 4.5 using citrate buffer and hydrochloric acid, and notably, it does not contain any preservatives. This innovation aims to improve the delivery and absorption of calcitonin, a hormone used in various therapeutic applications.
Career Highlights
Salvatore Mardente is associated with Alfa Wassermann, Inc., a company known for its commitment to research and development in the pharmaceutical sector. His role at the company has allowed him to focus on advancing drug formulations and improving patient outcomes through innovative solutions.
Collaborations
Mardente has worked alongside Leone G Rotini, contributing to the development of new pharmaceutical technologies. Their collaboration has been instrumental in pushing the boundaries of current pharmaceutical practices.
Conclusion
Salvatore Mardente's contributions to pharmaceutical compositions highlight his innovative spirit and dedication to improving healthcare solutions. His patent for calcitonin spray dosing exemplifies the potential for advancements in drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
